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INTRODUCTION
The mentally ill patient has long been a major medical problem.
Large numbers of our population need and receive help every year for
mental illness.

If a person has a physiological abnormality, such

as a biochemical aberration, whether it effects his perception or
his emotional control, he may not be able to respond to even highly
trained professionals when it is viewed as a psychological disorder.
If the correctable physiological abnormalities are found in even a
small percentage of cases, treatment of these abnormalities could
mean improvement for large numbers of children and adults with
diagnosis of autism, paranoia, schizophrenia, minimal brain
dysfunction, depression and other mental diseases.
The methods principally used now for treating patients with
mental illnesses are psychotherapy (Marmor, 1961; Wynne
1963; Luborsky, Singer

&

&

Singer,

Luborsky, 1975), chemotherapy (Hollister,

1977), and convulsive or shock therapy (Riddell, 1963; Abrams
Fink, 1972; Fink, 1978).

&

More is needed than the time tested tools

of the history, physical examination and laboratory work-up to
reveal the interplay between environmental and bodily factors which
characterize many mental illnesses.

Linus Pauling concluded that,

"Another method of treatment, which may be called orthomolecular
therapy, may be found to be the best method of treatment for many
patients."

(1968, p. 265)
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Much has been learned during the last decade about the
diagnosis and treatment of biochemically based mental illness.
However, orthomolecular therapy is not fully understood by the
medical profession and, considered a proven technique in treating
the mentally ill.

An

analysis of materials available to medical

professionals, educators and counselors, demonstrates the knowledge
of these correctable physiological abnormalities is not widely
published.
This paper will not attempt to include all known biochemical
causes of mental illness included in orthomolecular therapy, such
as; environmental chemicals, allergies, hypoglycemia, diabetes,
hormonal imbalance, pollutants or dietary considerations.

Instead,

it will focus on the literature illustrating the relationship
between mental illness and vitamin deficiency.

In this study, the

terms vitamin and nutrient are used interchangeably.

OR'IHOMOLECULAR THERAPY
Orthomolecular therapy is the achievement and preservation of
mental health by varying the concentration in the human body of
substances that are normally present, such as vitamins.

The term

"orthomolecular" was first utilized by Nobel Laureate Linus Pauling
(1968) to characterize the treatment of disease with nutrients that
are endogenous to the human body.

Orthomolecular simply means "right

molecule" or essential nutrient given at the right time.
therapy is better called "meganutrient" therapy.

"Mega-vitamin"

Treatment with
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adequate nutrients is the distinguishing therapy of orthomolecular
therapy.
Orthomolecular therapy does not deny that many mental illnesses
are triggered by stress, sudden shock, trauma or an accumulation of
disappointments and frustrations.

However, orthomolecular therapy

maintains that the primary causative factors in these cases is a
biochemical one that is either preexistent or brought on by the
stressful experience.

Only when the nutrient environment of the

brain has been altered to correct the condition, will the mental
illness cease.

This is accomplished with the treatment of vitamins.
Vitamins

Vitamins are organic food substances found only in living
things, that is, plants and animals.

There are about twenty

substances that are believed to be active as vitamins in human
nutrition.

Each of the vitamins is present in varying quantities

in specific foods, and each is absolutely necessary for proper
growth and maintenance of health.

With a few exceptions the body

cannot synthesize vitamins; they must be supplied in the diet as a
dietary supplement.
Vitamins have no caloric value or energy value but are
important to the body as constituents of enzymes which function as
catalysts in nearly all metabolic reactions.

As such, vitamins help

regulate metabolism, help convert fat and carbohydrates into
metabolic energy and assist in forming bone and tissue.
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The range of vitamins with psychochemical importance is broad.
According to Linus Pauling;
The proper functioning of the brain is known to
require the presence of molecules of many different
substances. For example, mental disease, usually
associated with physical disease, results from low
concentration in the brain of any of the following
vitamins: thiamine (Bl), nicotinic acid or
nicotinomide (B3), pyridoxine (B6), Cyanocobalamine
(B12), pantothenic acid, folic acid and ascorbic
acid (Vitamin C). (p. 265)
The following is a partial listing of the symptoms brought
about by the deficiency of the aforementioned vitamins:
Vitamin Bl (thiamine)
Thiamine is a water soluable vitamin that combines with pyruvic
acid to form a coenzyme necessary for the breakdown of carbohydrates
into glucose, or simple sugar, which is then oxidized by the body
to produce energy.

Conmen sources of Bl are:

Brewer's yeast, brown

rice, organ meats, egg yolks, nuts, whole grains, fish and poultry.
Thiamine deficiency causes loss of appetite, generated by cell
malnutrition in the hypothalamus (Williams, 1971). This makes it
difficult for an individual to digest carbohydrates but this also
leaves too much pyruvic acid in the blood.

This causes an oxygen

deficiency that results in loss of alertness, labored breathing and
cardiac damage.

Other symptoms include, depression, irritability,

confusion, loss of memory, inability to concentrate, fear of
impending doom, and sensitivity to noise.

These symptoms, related

to mild mental disease, disappear with the administration of
thiamine (Williams, 1971; Bruno, 1973).
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Vitamin B3 (niacin)
As a coenzyme, niacin assists enzymes in the breakdown and
utilization of proteins, fats and carbohydrates.

Lean meats,

poultry, wheatgerm, fish and peanuts are rich sources of niacin.
Niacin is difficult to obtain except from these foods.

The

earliest manifestation of pellagra, created by a severe deficiency
of niacin, are anxiety, depression, fatigue, and vague somatic
complaints (Joliffe, 1939; Joliffe, Bowman, Roseblum & Fein, 1940;
Frostig & Spies, 1940; Hoffer, 1973).

Frostig and Spies (1940)

examined 60 patients with subclinical and mild pellagra, with an
initial syndrome of hyperesth~sia, hyperactivity, depression,
apprehension, fatigue, headaches, and insomnia.
As the disease progresses, patients often complain of failing

vision, hypersensitivity to light, illusions, vertigo, visual and
auditory hallucinations, hyperacute sense of smell, dulled sense
of taste and persistent salty taste.

These perceptual changes are

very similar to those produced by schizophrenia and by the
hallucinagens (Hoffer & Osmond, 1966).
Vitamin B6 (pyridoxin)
Pyridoxin plays an important role as a coenzyme in the breakdown
and utilization of carbohydrates, fats, and proteins.

It must be

present for the production of antibodies and red blood cells.

Of

the 12 known disorders involving genetic vitamin dependency,
pyridoxin is involved in 5 (Rosenberg, 1970).

This vitamin is the

precursor to 50 enzymes, necessary for the metabolism of all amino
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acids and required for the maintenance of a stable immunological
system (Axelrod & Trakatellis, 1964; Davis, Nelson & Shepard, 1970;
Ellis, 1973; Philpott, 1974). The best sources of pyridoxin are
meats and whole grains.
Cyannocobalamine (B12)
Cyannocobalamine is necessary for normal metabolism of nerve
tissue.

The best sources of B12 are fish, pork, eggs, cheeses, and

milk products.

A higher incident of low B12 concentration has been

found in mental patients than in the normal population.
Deficiencies cause pernicious anemia, with mental symptoms ranging
from poor concentration to stuperous depression, severe agitation
and hallucinations (Hatt, 1971).
Pantothenic acid
Pantothenic acid plays a vital role in cellular metabolism.
Organ meats, brewer's yeast, egg yolks, and whole grain cereals are
the richest sources. Volunteers fed a diet deficient in pantothenic
acid became easily upset, irritable, sullen, tense, dizzy,
depressed, and numb (Wormsley & Darrough, 1955; Eiduson, Geller,
Yuiviler & Eiduson, 1964).

Both animal and humans withstand stress

better after receiving large doses of pantothenic acid (Williams,
1971).
Folic acid
Folic acid combines with B12 and Vitamin C, in the breakdown
and the utilization of proteins.

The best sources are green leafy

vegetables, liver, and brewer's yeast.

Several surveys revealed
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low folic acid levels in the blood of 40 to 80 percent of the
geriatric psychiatric patients.

A number of the subjects were

benefited by administration of high levels of folic acid (Williams,
1971). However, deficiertcy reappeared unless sufficient Vitamin C
was supplied to convert folic acid into usable form (Scheid, 1952;
Greenberg, 1957; Herbert, 1963).
Vitamin C (ascorbic acid)
A primary function of Vitamin C is maintaining collagen, a
protein necessary for the formation of connective tissue in skin,
ligaments, and bones. Vitamin C is present in most fresh fruits
and vegetables.

Research indicates that almost any physical or

mental stress significantly reduces Vitamin C levels in plasma
(Urbach, Hickman & Harris, 1952; Mass, Gleser & Gottschalk, 1961;
Baker, 1967).

Deficiencies of Vitamin C can cause listlessness,

decreased epinephrine response, and increased susceptibility to
vascular stress (Dayton & Weiner, 1961).
The Recommended Daily Allowances (RDA) of vitamins are
considered "to be adequate to meet the known nutritional needs of
practically all healthy persons" (National Academy of Science, 1980,
p. 1). The estimate is dependent on two assumptions:

first, that

nutrient requirements in normal, healthy people are distributed
according to the Bell-Curve distribution, and second, that the
standard deviation for nutrient requirements is generally about 15
percent of the mean.
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The RDA fails to consider the concept of "biochemical
individuality." Simply put, it means there are no "average human
beings.

Instead, each of us is biologically unique.

Williams has

demonstrated that virtually everything about us--the size and shape
of our organs, the speed of our metabolism and our requirements for
nutrients--can vary enormously from one individual to the next.
Each human being possesses a highly distinctive
body chemistry. While the same metabolic processes
are operating in all human bodies, the structures
are significantly diverse and the genetically
determined enzyme efficiencies vary sufficiently
from individual to individual so thp.t the sum
total of all the reactions taking place in one
individual's body may be very different from those
taking place in the body of another individual of
the same age, sex, and size. (Williams, 1977,
p. 166).
Genetrophic Concept
Williams and co-workers (1973) reported the ranges of hl.Jilan
requirements for amino acids and other nutrients are from 2 to 7
times with an average range of 4 times in groups of fifteen to
fifty-five subjects.

Hegsted (1963) concluded that amino acid

requirements often vary by more than 2 times the normal range; in
fact, analysis of Hegsteds work, can be interpreted as indicating
ranges of 3 to 9 times greater in small groups of normal college
women.
Inborn genetic differences are the only known factors adequate
to explain the large variations in requirements found in normal
healthy hl.Jilans and animals. Genetically based variability might
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affect any stage of the nutritional process, including digestion,
absorption, transport, storage excretion or utilization.
If genetic impairment is sufficiently crucial and severe, it
will be fatal before birth.

If its nature and severity are somewhat

less profound, an individual may possess a clearly "abnormal" inborn
"error of metabolism" which may be more or less mitigated by
nutritional adjustments.

If the genetic impairment is still less

severe, the affected individual may be "normal" but require for his
or her optimum health atypical amounts of a specific nutrient.

There

is no reason to expect a sharp or even a definable division between
"abnormal defect" and "normal variation."
l

Whether the increased needs are primarily caused by the disease
or disability or are a cause of it will determine the duration of
the appropriate nutrient adjustments.

Temporarily enhanced nutrient

needs may serve primarily to compensate for increased utilization
or losses, or to stimulate and enhance various natural mechanisms
of resistance and healing.

Temporarily high apparent requirements

may be caused by long standing m81lrginal or inadequate intake and
a slow process of restoring tissue concentrations to normal.
These genetrophic diseases in humans include a variation of
"maple syrup urine disease" which responds to thiamine (only 10-30
mg/day; 7-20 times the RDA), a form of methyl malonic acidernia which
responds to vitamin B12 injection (1 mg/day; 300 times the RDA), a
variation of propconic acidernic which responds to biotin (10 mg/day;
70 times the RDA) and Hartrup's disease which involves increased
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requirements for niacin (Wong

&

Hsia, 1973; DeLuca, 1979). The best

known human examples include severe metabolic disease which respond
to increased intake of vitamin B6 (Mudd, 1971), and "vitamin
D--resistant rickets," a group of disorders which often responds to
increased intakes of vitamin D3 or its normal metabolite (Deluca,
1979).
These examples illustrate the important point that despite
definite sounding names and "diagnostic" biochemical indicators,
"inborn errors of metabolism," differ in their severity, the age
of onset and the involvement of various organs.

It is these

nutritional differences, genetic differences and clinical
nutritional variances that furthers the concept that the treatment
of mental illness is the provision of the optimum molecular
concentration of the brain especially the optimum molecular
concentration of substances present in the human body from individual
to individual.
Biogenic Amine Theory
Three quarters of a century ago a C,ambridge graduate student
introduced the concept of the neurotransmitter or the biochemical
vehicle of neuron impulse transmission, a hypothesis which
eventually led to the identification, by Axelrod (1972), of
norepinephrine (NE).

Since the identification of norepinephrine

(NE) at least eight other chemicals have been characterized as
neurotransmitters (Maas, 1975):

serotonin (5-HT), dopamine (DA),

acetylcholine (ACh), histamine, inhibitory amino acids (GABA),
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substance P (a polypepide and prostagladin).

Maas believes dopamine

(DA), norepinephrine (NE), and serotonin (5-HT) are related to mental
illness, the first, DA, to psychosis, the two NE and 5-HT specifically
to depression.
These three substances norepinephrine (NE), dopamine (DA), and
serotonin (5-HT) have come to represent the Biogenic Amines Theory.
Norepinephrine (NE)
(

This neural system has a major role in affecting states. The
destruction of NE neurons can result in withdrawn, asocial,
anhedonistic "depressive-like" behavior.

During states of emotional

stress an increase in NE turnover occurs.

Since NE is involved in

the pleasure and reward center of the hypothalamus, dysfunction in
its metabolism could result in distinct mood change.
Dopamine (DA)
Excessive amounts of dopamine may result in abnormal motor and
mood states.

Latent schizophrenic states have been activated in

patients by L-Dopa (precursor to dopamine) and manic-like states
have been evoked in depressed patients and manic-depressive patients.
Serotonin (5-HT)
There appears to be significant disturbances of serotonin in
depressed patients.

Evidence indicates a basic deficiency in

serotonin turnover in the central nervous system of patients during
both remitted and depressed states.
Fischer (1973) presented an extensive review and discussion of
the Biogenic Amine Theory.
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One can look for the effect of vitamins on neurotransmitters
for a possible explanation for the management of mental illness.
Niacin or niacinamide in mega (meaning massive) doses impedes the
breakdown of tryptophan, a precursor of serotonin; thus it would
be helpful in those states of depression with deficiency of
serotonin, the type of depression expected,to react to drugs
blocking the reuptake of serotonin.

Adequate levels of pyridoxin

(vitamin B6) are necessary for the synthesis of serotonin and for
the conversion of dopa to dopamine, the precursor of norepinephrine;
therefore, vitamin B6 is potentially helpful in both chemical types
of depression, the "serotonin depression" and the "norepinephrine
depression." Ascorbic acid (vitamin C) is essential in the
conversion of dopamine to norepinephrine.

Therefore, both B6 and

vitamin C in megadoses could have beneficial effects in those
individuals who have shown a reduction of depression to drugs
inhibiting norepinephrine reuptake.
Neuropharmacologists now have ample evidence nutrition can
influence the production and concentration of neurotransmitters
which they have always equated with the action of drugs to influence
behavior, such as tranquilizers and antidepressants.
Thomas and Zemp (1977), and Tolbert, Thomas, Middaugh and Zemp,
(1979), found that ascorbic acid is as potent a substance as Haldol
in blocking dopamine receptors in the brain.

Nicotinamide, one

of the B3 members also has an effect on brain receptors.

A class

of antianxiety drugs, the diazepines (Valium, Librium, Serax) are
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attracted to diazepine receptors in the brain.

Mohler, Pole, Cumin,

Pieri and Kettler (1979), discovered that nicotinomide is also
attracted to these receptors.

They suggest nicotinomide is the

natural molecule with benzo-diazepine-like action.

These findings

have clearly shown how vitamins can have a direct effect on brain
receptors that are independent of how they a~e made or from which
precursor.
Vitamin Therapy
The first use of a vitamin in treating mental illness in
patients without pellagra was Cleckley, Sydenstricker, and Gieslin
(1939), who successfully treated 19 patients with 100 mg to 300 mg
of niacin.

It was also recognized at the time that therapeutic

(larger than normal) doses of nutrients are needed to overcome
illness of various kinds (Mc.Lester, 1939).
Some states which are psychologically diagnosed
as functional illness may originate from
nutritional deficiencies, and some states which
are psychologically diagnosed as functional
mental illness may be relieved by appropriate
nutritional therapy. (p. 326)
A study by Hoffer, Osmond, Callbeck and Kahan (1957) reported
successful use of three grams of vitamin B3 for treating schizophrenia.
They conducted the first double blind studies in psychiatry in which
neither the evaluators nor the caretakers knew which patients were
receiving experimental treatment.

In their niacin studies they

did extensive follow-up evaluation of patients discharged from
the hospital over a five year period in which they evaluated

14

treatment effectiveness on several different levels having to do
with perceptual distortions and family and community adjustment.
They were thus able to demonstrate that niacin B3 decreases
schizophrenia symptoms in a statistically significant number of
patients (Hoffer, 1962).

Likewise, Wittenborn (1974), showed that

acute schizophrenics improved on a large variety of measures when
given three grams of niacin per day for two years.
Green (1970) described a schizophrenic-like syndrome in both
children and adults who appeared healthy, having no clinical
symptoms but many physical complaints.

He called this syndrome

subclinical pellagra, since vitamin B3 was able to relieve the
symptoms.

He found that in 1100 public school children in Prince

Albert, Saskachewan, 17 percent showed signs of subclinical pellagra.
Alan Cott (1971) reported clinical evidence that massive
doses of vitamin B3, B6, C and E decrease the symptoms of
schizophrenic children and adults and of autistic children.

He also

reported that the less disturbed learning disabled child responds
to vitamin B3, B6, C and pantothenic acid within three to six months
of treatment.

Thiessen and Mills (1975) reported in a matched

control study that these four vitamins, given over a period of a
year to learning disabled children with normal I.Q., reduced
hyperkinesis, sleep disturbances, nystagmus and certain perceptual
disturbances.

Some basic language skills as measured by four

subtests of the Illinois Test of Psycholinguistics Ability (ITPA)
were also improved.
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Watson (1965); Pfeiffer, Ilier and Goldstein (1973); Rirnland
(1973); and Blackwood (1975) reported the need to individualize
nutrient supplements for either the mentally disturbed child or
adult. While certain adults with mental and emotional
illnesses benefit from nutritional supplementation programs,
others developed metabolic disturbances with either no improvement
l

or exascerbation of their symptoms.

Pursuing this observation with

metabolic studies and a step-by-step evaluation of separate nutrients,
Watson (1965) discovered that he could divide such individuals
into what he called "slow and fast glucose oxidizers." Slow
oxidizers particularly benefited from vitamins B1, B2, and B6 while
fast oxidizers were especially improved with pantothenic acid,
choline and vitamin E.

Other nutrients play a paradoxical role but

to a lesser degree.
Rimland (1973) started autistic children on a Recommended
Dietary Allowance (RDA) level B complex with 10 mg of iron and 500
mg of vitamin C; two weeks later added 500 mg of niacinamide and 75
mg of B6, and finally three weeks later added 100 mg of pantothenic

acid.

He found that most children benefited directly with the

clearing of skin problems; normalization of appetite, whether
excessive or lacking; increased alertness and social awareness;
greater calmness; more assessibility; greater fluidity of speech;
and greater pressure to talk.

However, he found that 4 of 190

children became either more wild or more withdrawn on niacinamide
and pyridoxin (B6).

He also found, in keeping with Watson's work,
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that a few children improved dramatically when pantothenic acid was
added, while in others this led to deteriorated behavior.
The invention of other theories regularly and
appropriately evokes the same response from
sorne of the specialists on whose area of
special competence they impinge. For these
men the new theory implies a change in the
rules governing the prior practice of normal
science. Inevitably, therefore, it reflects
upon much scientific work they have already
successfully completed. That is why a new
theory, however special its range of
application is, is seldom or never just an
increment to what is already known. Its
stimulation requires the reconstruction of
prior theory and the re-evaluation of
prior fact, an intrinsically revolutionary
process that is seldom completed by a
single man and never overnight. (Kuhn,
1970, p. 20)
Vitamin Therapy Resistance
To comprehend the resistance found in the use of orthomolecular
therapy, it is useful to review what communication research
indicates are some of the problems involved in introducing ideas and
changing professional opinion.
Besides an open channel and the acknowledged expertise of the
comnunicator, other factors which determine the effectiveness of a
corrmunication involve the receiver of the message.

For the receiver

to accept the message he must feel his self-esteem to be enhanced
by it.

An approach such as orthomolecular therapy is a criticism

and an embarrassment to the average physician who has no training in
nutrition in medical school and for the psychiatrist whom the idea
is especially difficult because of his commitment to the psychogenic
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etiology of mental illness.

Also, the psychotherapy he offers

provides him with compelling, interesting work for which he has
in-depth training and in which he has a great investment.

Doctors

whose income would be threatened if patients turned elsewhere for a
different treatment modality are not likely to feel their self-esteem
enhanced by the orthomolecular approach.

The receiver to accept a
)

message must also find that it provides some significant compensation,
like money.
Acceptance of the message is influenced also by the discrepancy
between message and what the receiver believes.

The policy of

orthomolecular therapy, to support the body's constructive
mechanisms, runs counter to current medical practice with its
emphasis on suppressing the body's defenses, that is, the symptoms
which often are labeled as diseases.

Discomfort in the presence of

such discrepancy leads to avoidance by means of dismissing the
influence with statements of "anecdotal", "unscientific", and "no
double-blind studies".
In July 1973, a Task Force (APA, 1973) of five physicians and
one consultant issued a 54-page report "Megavitamin and
Orthomolecular Therapy in Psychiatry." The Task Force reports to
present both theoretical and emperical reasons for the achievement
and preservation of good mental health.
The Task Force expresses rather limited understanding of the
nature of vitamins.

"By common definition a vitamin is not only an

essential nutrient, but it is essential because it is transformed
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into a coenzyme vital for metabolic reactions" (p. 41). This is
not the cormnon definition of a vitamin.

Some vitamins, including

vitamin C, are not known to be transformed into a coenzyme. This
limited definition by the Task Force may have contributed to the
misinterpretation of the evidence for the theoretical basis of
orthomolecular therapy.
The APA Task Force report repeatedly mentions the use of 1
to 30 grams of ascorbic acid a day by orthomolecular psychiatrists.
There are, however, no references to the literature.
there are significant omissions.

In addition,

Milner's double-blind study,

(1963), is not mentioned, nor is there any discussion of the many
papers in which a low level of ascorbic acid in the blood of
schizophrenics was reported (Horwitt, 1942; Vanderkamp, 1966; &
Herjanic, 1973). Neither the general theory of orthomolecular
therapy, nor any of the special arguments about the value of
ascorbic acid are presented or discussed in any significant way.
There is, moreover, no discussion in the report of pyridoxin and
no reference to Ananth, Ban, and Lehman (1973), work on the
potention by pyridoxin of the effectiveness of niacin in controlling
chronic schizophrenia.
The Task Force refers to the low credibility of the
orthomolecular proponents; "their credibility is further diminished
by the consistent refusal over the past decade to perform controlled
experiments and to report their new results in a scientifically
acceptable fashion" (p. 49).

However, Osmond and Hoffer (1962)
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and Denson (1962) carried out controlled trials.

They became

convinced that orthomolecular therapy, along with conventional
treatment, was beneficial to almost every patient.

From that time

on their ethical principles have required that they give this
treatment and not withhold it from half of their patients.
Nutritional Counseling
There is a transition occuring, slowly, in the conceptualization
of the process of treatment provided in counseling and psychology.
There is movement towards preventative health care with an emphasis
on wellness and self-responsibility.

However, counselors and

psychologists are trained that what they will encounter in their
clients is psychological in origin.

There is a great deal of

evidence that this is mistaken and that most of mental illness is
misdiagnosed as a result of this dualistic approach to human
behavior (Fredericks, 1976; Hoffer & Walker, 1978; Schauss, 1978,
1980).
A number of correctional and residential programs have
instituted nutritional and lifestyle assessments in their diagnostic
procedures with effectiveness of treatment increasing dramatically
(Schauss, 1978; Worden & Rosellini, 1978; Reed, 1983). However, a
review of the literature on nutritional training for counselors,
psychologists and medical students reveal some startling facts.
Vass (1983) found that counseling programs have little emphasis on
nutrition information in their training programs.

Only one program

indicated a separate course available and none of the programs
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offered more than one course.

The receptivity of the students for

nutritional education was greater (17.4%) than the faculty support
(10.5%). The possibility of future curriculum development is not
encouraging.
The counseling field is falling far behind the nutritional
fields in the exploration of the literature and the revelance of
this literature in training programs.

It is aisturbing that health

care professionals are being turned out with so little knowledge
on the relationship of nutrition to mental illness.
All health care professionals cannot be experts in nutrition.
It is reasonable to expect that dietary history along with basic
questions on lifestyle be included in any diagnostic procedure.
There are a number of assessment tools available to assist counselors
in utilizing differential diagnostic procedures (Kaslow & Miles,
1979; Schauss, 1980; Vass, 1981; Reed, 1983, 1984).
Toe most limiting factor a counselor encounters in an
orthornolecular practice is his credentials.

Orthomolecular therapy

is a medical procedure and to practice requires a medical degree.
Thus, a counselor must move from a psychological counseling framework
to a medical model and a medical practice.
One must consider that any statement on the counselors part
that implies a person's difficulties may be due to a chemical
imbalance, hypoglycemia, vitamin deficiency or allergies, rather
than psychological, represents a medical judgement and moves the
counselor into diagnosing a medical problem.

By being unable to
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diagnose, the counselor's role is reduced to history taking.

The

history procedure involves only information gathering with the
medical problems being kept to description of symptoms and not the
identification of physical problems that cause the symptoms.

This

is complicated further, in that a counselor cannot make
reconmendations for medication, vitamin therapy or diets, basic to
orthomolecular therapy.

Again, this implies'a medical diagnosis

of a physical problem.
Presently, a counselor in an orthomolecular practice is a
potential liability for the supervising physician rather than an
asset.

Because the physician is ultimately responsible for the

decisions of the counselor, the counselor must be limited in his
duties. This provides the physician with optimum supervision and
patient management.

Limiting the duties of the counselor ensures

each patient is seen by the physician, diagnosed by the physician
and the treatment is established and maintained by the physician.
If the medical establishment is not ready to accept
orthomolecular physicians, they are not willing to accept
orthomolecular counselors.
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